Sei Investments Co. grew its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 21.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 59,425 shares of the company’s stock after acquiring an additional 10,373 shares during the quarter. Sei Investments Co.’s holdings in Clorox were worth $6,157,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in CLX. State Street Corp boosted its holdings in Clorox by 3.5% in the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after purchasing an additional 282,794 shares during the last quarter. Invesco Ltd. raised its stake in Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after buying an additional 884,751 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Clorox by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after buying an additional 10,060 shares during the period. Van ECK Associates Corp lifted its holdings in shares of Clorox by 15.7% during the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after buying an additional 426,433 shares during the period. Finally, Two Sigma Investments LP boosted its stake in shares of Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.
Trending Headlines about Clorox
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Clorox reported fourth-quarter adjusted earnings of $1.66 per share, exceeding the $1.64 analyst consensus, while revenue of $1.95 billion also surpassed the $1.91 billion estimate. Clorox Q4 Earnings and Revenues Surpass Estimates
- Positive Sentiment: The company forecast fiscal 2027 sales of approximately $7.6 billion to $7.7 billion, above the roughly $7.5 billion consensus. Management cited improving demand in health and wellness products and international markets despite continued macroeconomic uncertainty. Clorox Forecasts Upbeat Annual Sales as Demand Improves
- Positive Sentiment: Clorox raised its quarterly dividend to $1.25 per share from $1.24, supporting the stock’s income appeal with an indicated yield of roughly 5.2%. The dividend is payable August 28 to shareholders of record August 12.
- Neutral Sentiment: The outlook reflects recovery potential following the GOJO acquisition and completion of the U.S. enterprise-resource-planning implementation, but the integration and strategic investments may continue to affect near-term results. Clorox Reports Q4 and FY26 Results
- Negative Sentiment: Fiscal 2026 was weaker: annual sales declined 5% to $6.72 billion and diluted EPS fell 26% to $4.81. Fourth-quarter sales decreased 2%, while reported diluted EPS dropped 50% to $1.34, reflecting elevated costs and business-transition pressures. Clorox Q4 Sales Fall 2 Percent to $1.95 Billion
- Negative Sentiment: Fiscal 2027 EPS guidance of $5.70 to $6.00 is below the $6.23 analyst consensus, signaling that inflation, value-seeking consumers, acquisition costs and ongoing investments could constrain profitability even as sales recover.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on Clorox
Clorox Price Performance
NYSE CLX opened at $98.25 on Tuesday. The business’s fifty day moving average is $95.57 and its 200 day moving average is $103.57. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $128.90. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company has a market capitalization of $11.88 billion, a PE ratio of 15.95 and a beta of 0.54.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue for the quarter was down 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Sell-side analysts predict that The Clorox Company will post 5.52 earnings per share for the current year.
Clorox Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 annualized dividend and a yield of 5.1%. This is an increase from Clorox’s previous quarterly dividend of $1.24. Clorox’s payout ratio is currently 80.52%.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
- Five stocks we like better than Clorox
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
